Conductor and composer Michael Tilson Thomas, the Music Director Laureate of the San Francisco Symphony, passed away on April ...

Michael Tilson Thomas, a Grammy-winning conductor, composer and pianist who spent 25 years as the San Francisco Symphony’s ...

A novel technique for treating GBM first underwent a phase 1 clinical trial with patients who had recurrence of their cancers after their primary treatment, and was published in the journal ...

BOSTON--(BUSINESS WIRE)--BPGbio, Inc., a leading biology-first, AI-powered, clinical stage biopharma focused on mitochondrial biology and protein homeostasis, today announced that researchers will ...

Metabolic profiling using Seahorse analysis showed that CCR5 inhibition reduced oxygen consumption rate (OCR) in a dose-dependent manner, consistent with modulation of glycolytic and metabolic ...

Dublin, April 02, 2026 (GLOBE NEWSWIRE)-- The "Glioblastoma Multiforme (GBM) Treatment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers comprehensive insight ...

Half of patients with GBM present with headaches at diagnosis, which is attributed to increases in intracranial pressure (Table 2). 11 Papilledema, now rarely seen because imaging is typically ...

Variation over time and interdependence between disease progression and death among patients with glioblastoma (GBM) on RTOG 0525. Background: Current standard treatment for GBM consists in ...

Cintredekin besudotox targets IL-13 alpha-2 receptor in glioblastoma, aiming to spare healthy brain tissue while destroying cancer cells. Orphan drug designation offers benefits like lower fees and ...